EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL

N/A

Manufactured by Kenvue Brands LLC

537 FDA adverse event reports analyzed

Last updated: 2026-04-15

About EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL

EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Kenvue Brands LLC. The most commonly reported adverse reactions for EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL include DRUG ABUSE, DIARRHOEA, NAUSEA, VOMITING, STOMATITIS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL.

Top Adverse Reactions

DRUG ABUSE25 reports
DIARRHOEA20 reports
NAUSEA20 reports
VOMITING17 reports
STOMATITIS15 reports
FEBRILE NEUTROPENIA14 reports
DYSPNOEA13 reports
DYSPHAGIA11 reports
MUCOSAL INFLAMMATION11 reports
PAIN11 reports
DEHYDRATION10 reports
HEADACHE10 reports
INTENTIONAL PRODUCT MISUSE10 reports
DECREASED APPETITE9 reports
HAEMOGLOBIN DECREASED8 reports
LOSS OF CONSCIOUSNESS8 reports
ORAL CANDIDIASIS8 reports
ORAL PAIN8 reports
WEIGHT DECREASED8 reports
ASTHENIA7 reports
DIZZINESS6 reports
DRUG DEPENDENCE6 reports
FATIGUE6 reports
HEART RATE INCREASED6 reports
MALAISE6 reports
PYREXIA6 reports
APPLICATION SITE PAIN5 reports
CONFUSIONAL STATE5 reports
COUGH5 reports
DRUG INEFFECTIVE5 reports
DYSPHONIA5 reports
HYPERSENSITIVITY5 reports
NEUTROPENIA5 reports
PNEUMONIA5 reports
PRODUCT QUALITY ISSUE5 reports
RASH5 reports
SEPSIS5 reports
SWOLLEN TONGUE5 reports
ACCIDENTAL EXPOSURE TO PRODUCT4 reports
AGEUSIA4 reports
CANDIDIASIS4 reports
CHEST PAIN4 reports
DRY MOUTH4 reports
GENERAL PHYSICAL HEALTH DETERIORATION4 reports
HYPERHIDROSIS4 reports
HYPOPHAGIA4 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION4 reports
INCORRECT ROUTE OF DRUG ADMINISTRATION4 reports
MOUTH ULCERATION4 reports
ORAL MUCOSAL EXFOLIATION4 reports
OROPHARYNGEAL PAIN4 reports
PANCYTOPENIA4 reports
PLATELET COUNT DECREASED4 reports
PSORIASIS4 reports
RESPIRATORY RATE INCREASED4 reports
THROAT IRRITATION4 reports
THROMBOCYTOPENIA4 reports
WHITE BLOOD CELL COUNT DECREASED4 reports
ABDOMINAL PAIN3 reports
ABDOMINAL PAIN UPPER3 reports
APHONIA3 reports
ARTHRALGIA3 reports
BACK PAIN3 reports
BACTERIAL INFECTION3 reports
BURNS THIRD DEGREE3 reports
CANDIDA INFECTION3 reports
COELIAC DISEASE3 reports
CONSTIPATION3 reports
CRYING3 reports
DENTAL CARIES3 reports
DISEASE PROGRESSION3 reports
ENCEPHALOPATHY3 reports
ERYTHEMA3 reports
GAIT DISTURBANCE3 reports
GLOSSODYNIA3 reports
HALLUCINATION, VISUAL3 reports
HYPOTENSION3 reports
HYPOXIA3 reports
LACERATION3 reports
OESOPHAGEAL CANDIDIASIS3 reports
ORAL DISCOMFORT3 reports
PRODUCTIVE COUGH3 reports
PULMONARY MYCOSIS3 reports
PULMONARY OEDEMA3 reports
RENAL IMPAIRMENT3 reports
SOMNOLENCE3 reports
TOOTH DISORDER3 reports
TOOTH LOSS3 reports
TOOTHACHE3 reports
TREMOR3 reports
VISUAL IMPAIRMENT3 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS3 reports
ABDOMINAL DISCOMFORT2 reports
ABNORMAL BEHAVIOUR2 reports
ACUTE KIDNEY INJURY2 reports
AGRANULOCYTOSIS2 reports
ALOPECIA2 reports
ANAPHYLACTIC REACTION2 reports
APHAGIA2 reports
APPLICATION SITE SWELLING2 reports

Report Outcomes

Out of 231 classified reports for EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL:

Serious 82.3%Non-Serious 17.7%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female106 (52.5%)
Male96 (47.5%)

Reports by Age

Age 688 reports
Age 106 reports
Age 446 reports
Age 486 reports
Age 645 reports
Age 705 reports
Age 574 reports
Age 714 reports
Age 724 reports
Age 734 reports
Age 453 reports
Age 523 reports
Age 553 reports
Age 583 reports
Age 593 reports
Age 653 reports
Age 853 reports
Age 132 reports
Age 142 reports
Age 302 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL?

This profile reflects 537 FDA FAERS reports that mention EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL?

Frequently reported terms in FAERS include DRUG ABUSE, DIARRHOEA, NAUSEA, VOMITING, STOMATITIS, FEBRILE NEUTROPENIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL?

Labeling and FAERS entries often list Kenvue Brands LLC in connection with EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.